8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC

8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China

8/8/2025Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...

8/8/2025AstraZeneca Expands Use of Fasenra in China

8/8/2025Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...

8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...

8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...

8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery

8/6/2025MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial

8/5/2025CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...

8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD

8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...

8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...

8/4/2025Novartis Submits Zolgensma for Approval in China with Priority Review ...

8/4/2025Alphamab's JSKN022 ADC Clears Major Regulatory Hurdle, Highlights Prec...

8/4/2025China Grants First-Time Approval to Eight New Drugs in July 2025

8/2/2025PD‑L1×VEGF Bispecific from ImmuneOnco Shows Strong Efficacy in China...

8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...

8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...

7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...

7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China

7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...

7/30/2025China Approves Domestic CD19 CAR-T Therapy Hengkailai

7/30/2025SPH Biothera Receives NMPA Clearance for CAR-T Therapy Targeting Refra...

7/29/2025Pfizer Launches Landmark Pneumococcal Vaccine Trial in China, Pioneeri...

7/29/2025Innovent Wins NMPA Clearance for IBI363 in Two New Cancer Trials

7/29/2025LENZ Moves Toward Approval in China with LNZ100 Submission

7/29/2025Bayer Files HER2+ Lung Cancer Drug in China

7/28/2025Antengene's XPOVIO® Wins Third Approval in China for Multiple Myeloma

Page:5/20 Total number of articles:596: [First][<<] [3] [4] [5] [6] [7] [>>] [End]